In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue

Anticancer Research

Volumn 17, Issue 3 A, 1997, Pages 1455-1460

  Heerschap, Arend ^a   Jager, Gerrit J ^a   Van Der Graaf, Marinette ^a   Barentsz, Jelle O ^a   De La Rosette, Jean J M C H ^a   Oosterhof, Gosse O N ^a   Ruijter, Emiel T G ^a   Ruijs, Sjef H J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cancer; Human prostate; Metabolites; MR spectroscopy

Indexed keywords

CHOLINE; CITRIC ACID; CREATINE;

ADULT; AGED; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTON NUCLEAR MAGNETIC RESONANCE;

AGED; CHOLINE; CITRATES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REFERENCE VALUES;

EID: 0030958436     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GP: The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 70 (suppl 1) 291 - 301, 1992.
2. Jager GJ, Barentsz JO, Ruijter ETG, de la Rosette JJMCH, Oosterhof GON: Primary staging of prostate cancer. Eur Radiol 6: 134- 139, 1996.
3. Schiebler ML, Schnall MD, Pollack HM, Lenkinski RE, Tomaszewski JE, Wein AJ, Whittington R, Rauschning W, Kressel HY: Current rote of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 189: 339-352, 1993.
4. Hricak H, White S, Vigneron D, Kurhanewicz J, Kosco A, Levin D, Weiss J, Narayan P, Carroll PR: Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorcctal-pelvic phased-array coils. Radiology W: 703-709, 1994.
5. Jager GJ, Ruijter EMT, van de Kaa CA, de la Rosette JJMCH, Oosterhof GON, Thornbury JR, Barentsz JO: Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR 166: 845 - 852, 1996.
6. 1H MR Spectroscopy of normal and malignant human prostates in vivo. J Magn Reson 87: 610 - 619, 1990.
7. 1H MR Spectroscopy of the human prostate in vivo In: "Proc., SMRM, 9th Annual Meeting, New York" pg 288, 1990.
8. Heerschap A, Jager G, de Koster A, Barentsz J, de la Rosette J, Debruyne F, Ruijs J: H MRS of prostate pathology. In: "Proc., SMRM, 12th Annual Meeting, New York" pg 213, 1993.
9. Lowry M, Manton DJ, Turnbull LW, Blackband SJ. Horsman A : Quantitative proton MRS assessment of citrate heterogeneity in normal prostate. MAGMA 2, 483 - 485, 1994.
10. Costello LC and Franklin LB: Concepts of citrate production and secretion by prostate. 1. Metabolic relationships. The Prostate 25: 25 -46, 1991.
11. Halliday KR, Fenoglio-Preiser C, Sillerud LO: Differentiation of human tumours from nonmalignant tissue by natural-abundance C NMR Spectroscopy. Magn Reson Med 7: 384-411, 1988.
12. 1H NMR. Magn Reson Med 25: 140- 147, 1992.
13. 1H magnetic resonance spectroscopy and biochemical study. Magn Reson Med 29: 149 -157, 1993.
14. Schiebler MR, Miyamoto KK, White M, Maygarden SJ, Mohler JL: In vitro high resolution 1H spectroscopy of the human prostate: benign prostatic hyperplasia. normal peripheral zone and adenocarcinoma. Magn Reson Med 29: 285 - 291, 1993.
15. 31P magnetic resonance spectroscopy. J Urol 750: 2019 - 2024, 1993.
16. Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak HJ, McDonald JM, Konely B. Narayan P: Citrate as an in vivo marker to discriminate prostate cancer from benign hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology 45: 459 - 466, 1995.
17. Ordidge RJ. Bendall MR, Gordon RA, Connelly A: Volume selection for in vivo biological spectroscopy. In: "Magnetic Resonance in Biology and Medicine" (Govil G, Khetrapal CL, Saran A, Eds), New Delhi, Tata McCraw-Hill, 1985, pp 386-397.
18. Bottomley PA: Spatial localization in NMR spectroscopy in viva Ann NY Acad Sci 508: 333 - 348, 1987.
19. Brown TR, Kincaid BM, Ugurbil K: NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci USA 79: 3523 - 3526, 1982.
20. 1H NMR spectroscopy and spectroscopy imaging of the human brain. In: MR speciroscopy. clinical applications and techniques (Young IR and Charles HC. eds), London, Martin Dunitz Ltd, 1996, pp 161 - 173.
21. Barentsz JO, Boetes C, Verstraete KL, Jager GJ, Mus RDM, Ruijs SH: Dynamic Gadolinium-enhanced MR imaging of the body. Clin MRL 5: 88 - 93, 1995.
22. Jager GJ, Barentsz JO, de la Rosette JJMCH, Peters H, Hanselaar A, Oosterhof GON. Value of dynamic subtraction turboFlash MR imaging in prostate cancer (abstr). Radiology 193: 316, 1994.
23. Heerschap A, Jager G, van der Granf M, Barentsz JO, Ruijs SHJ. Proton MR spectroscopy of the normal human prostate with an endorectal coil and a double spin-echo pulse sequence. Magn Reson Med, in press. 1997.
24. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Caroll P, Nelson SJ: Three-dimensional H-l MR spectroscopic imaging of the in situ human prostate with high (0,24-0.7 cm3) spatial resolution. Radiology 198: 795 - 805, 1996.
25. Negendank W: Studies of human tumors by MRS: a review. NMR in Biomed 5: 303-324, 1992.
26. Jager G, Ruijter E, van de Kaa C, de la Rosette J, Oosterhof G, Thornbury J, Ruijs J, Burentsz J: Dynamic turbo-FLASH subtraction technique for contrast-enhanced MR images of the prostate: correlation with histupathology, Radiology, in press. 1997.